60 DEGREES PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- 60 DEGREES PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $3.41M.
- 60 DEGREES PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.90M, a 64.71% decline year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $5.38M.
- 60 DEGREES PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $185.34K.
- 60 DEGREES PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2024 was $3.41M.
- 60 DEGREES PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2022 was $185.34K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $3.41M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $3.41M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $1.90M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $5.38M 10-Q · filed 2023-11-20 | |
| 2022-12-31 | $185.34K 10-K · filed 2024-04-01 | |
| 2022-06-30 | $185.34K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |